VJOncology is committed to improving our service to you

ESMO Breast 2020 | GELATO: carboplatin and atezolizumab in advanced lobular BC

VJOncology is committed to improving our service to you

Leonie Voorwerk

Leonie Voorwerk, MD, The Netherlands Cancer Institute, Amsterdam, The Netherlands, discusses the GELATO trial (NCT03147040), a single-arm, multicenter, non-randomized Phase II trial testing the efficacy of carboplatin and atezolizumab in metastatic lobular breast cancer (BC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter